Gefitinib Genthon

Gefitinib Genthon is an oral medication used to treat certain types of cancer. This pharmaceutical is manufactured by Synthon B.V. and is intended for oral use.

Gefitinib Genthon is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. It works by targeting specific proteins in cancer cells to slow their growth. This medication is often prescribed for patients with specific genetic mutations that make their cancer cells more responsive to gefitinib.

Common effects of Gefitinib Genthon may include skin rash, diarrhea, and appetite loss. Some users may also experience nausea, dry skin, or mild headaches. These effects vary among individuals and are not exhaustive.

Gefitinib Genthon should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies.

Gefitinib Genthon may interact with other medications, including certain antibiotics, antifungals, and seizure medications. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.